Turn Therapeutics Inc. (TTRX) News
Track canonical SquawkNews coverage tagged to TTRX, Turn Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Turn Therapeutics appoints Robert R. Redfield as chief scientific officer
Turn Therapeutics appointed Robert R. Redfield as chief scientific officer to advance scientific and clinical strategy for GX-03.
REGULATION | Sep 09, 2026, 12:13 PM UTC
L
Turn Therapeutics appoints Robert R. Redfield as Chief Scientific Officer
Turn Therapeutics Inc. announced the appointment of Robert R. Redfield, M.D., as Chief Scientific Officer. The company is a clinical-stage biotech focused on targeted, non-systemic therapies for inflammatory and infectio
EQUITY | Sep 09, 2026, 12:00 PM UTC